Ultivue Revenue and Competitors
Estimated Revenue & Valuation
- Ultivue's estimated annual revenue is currently $21.2M per year.
- Ultivue received $20.0M in venture funding in January 2018.
- Ultivue's estimated revenue per employee is $155,000
- Ultivue's total funding is $107.3M.
- Ultivue has 137 Employees.
- Ultivue grew their employee count by 29% last year.
Ultivue Competitors & Alternatives
|Competitor Name||Revenue||Number of Employees||Employee Growth||Total Funding||Valuation|
What Is Ultivue?
Ultivue develops innovative reagent-based solutions that maximize the biological information available from cells and tissue samples. The company's patent-pending technology is being used to elucidate biological pathways and to validate clinically-relevant biomarkers. Ultivue is based in Cambridge, MA. Our culture provides an exceptional work environment fostering innovation and collaboration to make a difference collectively. Ultivue's employees are bright, flexible, and driven to create meaningful impact through our work. We work at a fast pace, but support each other achieve the work/life balance that helps us thrive as a company. Our entrepreneurial culture relies on contributions and input from all. Our bench of experienced managers provides mentoring and support to ensure front line staff make the most of their unique talents and energy. Open Positions Ultivue provides unique opportunities for talented individuals to bring all of themselves--their passion, expertise and creativity--to bear on collectively solving problems that matter: - Field Application Scientist (FAS), Customer Engagement - Senior Accountant, General and Administrative - Research Assistant, Reagent Qualification, Research and Development - Research Assistant, Reagents, Research and Development - Scientist, Research and Development - Sales and Marketing; Commercial See job descriptions on our website https://www.ultivue.com/careers. To apply, please send your CV referencing the job title to email@example.com:Biotechnology,Healthcare,Pharmaceuticals
Number of Employees
Employee Growth %
Ultivue provides researchers in translational medicine with multiplex biomarker assays for tissue phenotyping and digital pathology. Its...
Ultivue Announces Multiple Events for Multiplex Immunofluorescence and Image Analysis Technology in Immuno-Oncology Research at AACR 2022.
--(BUSINESS WIRE)--Ultivue is thrilled to announce the addition of Professor Je Hyuk Lee in the role of Director of Research and Innovation, as...
Ultivue, a leader in advancing precision medicine solutions through a unique approach that combines multiplex biomarker analysis with same slide traditional H&E for tissue phenotyping, today announced the completion of a $50 million Series D round of financing. New investors include Ally Bridge ...
Ultivue, a developer of tissue biomarker identification and quantification assays for translational and pathology research labs, has completed a ...
|Company Name||Revenue||Number of Employees||Employee Growth||Total Funding|
|2015-10-14||$5.2M||A||ARCH Venture Partners||Article|
|2018-01-24||$20.0M||B||ARCH Venture Partners||Article|